推荐产品
形狀
liquid
品質等級
比活性
Antibacterial
濃度
50 mg/mL in DMSO
抗生素活性譜
Gram-negative bacteria
Gram-positive bacteria
mycobacteria
viruses
作用方式
protein synthesis | interferes
儲存溫度
−20°C
InChI
1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1
InChI 密鑰
JQXXHWHPUNPDRT-WLSIYKJHSA-N
一般說明
Rifampicin is a microlide antibiotic effective against gram-positive and gram-negative bacteria, mycobacteria and viruses.
應用
- Rifampicin is used to treat Tuberculosis and Tuberculosis-related mycobacterial infections.
- Rifampicin is widely used as an antipruritic agent in the autoimmune cholestatic liver disease, and primary biliary cirrhosis (PBC).
- Rifampicin was also found active by inhibiting Tau Oligomer Propagation in Alzheimer’s disease.
- Rifampicin is used as a selection agent for agrobacterium mediated plant transformation.
生化/生理作用
Inhibits the assembly of DNA and protein into mature virus particles.
Mode of Action: Inhibits initiation of RNA synthesis by binding to β-subunit of RNA polymerase.
其他說明
The product is supplied in DMSO at a concentration of 50 mg/mL. Working concentrations for agrobacterium selection are typically 10-50 mg/L.
危險聲明
危險分類
Lact.
儲存類別代碼
10 - Combustible liquids
水污染物質分類(WGK)
WGK 1
閃點(°F)
188.6 °F - closed cup
閃點(°C)
87 °C - closed cup
Guidelines for the Management of Cholestatic Liver Diseases (2021)
Journal of clinical and translational hepatology (2022)
Specific packaging of custom RNA molecules into cowpea mosaic virus-like particles
Methods in Molecular Biology, 103-111 (2022)
Treatment of rifampicin-resistant tuberculosis disease and infection in children: key updates, challenges and opportunities
Pathogens (Basel, Switzerland), 11.4, 381-381 (2022)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门